Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.230
-0.004 (-1.71%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Asensus Surgical Market Cap
Asensus Surgical has a market cap or net worth of $62.56 million as of March 28, 2024. Its market cap has decreased by -60.08% in one year.
Market Cap
62.56M
Enterprise Value
45.53M
1-Year Change
-60.08%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since December 1, 1998, Asensus Surgical's market cap has increased from $12.10M to $62.56M, an increase of 417.00%. That is a compound annual growth rate of 6.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 62.60M | -1.57% |
Mar 27, 2024 | 63.60M | 1.60% |
Mar 26, 2024 | 62.60M | -4.43% |
Mar 25, 2024 | 65.50M | 0.31% |
Mar 22, 2024 | 65.30M | -14.30% |
Mar 21, 2024 | 76.20M | 0.13% |
Mar 20, 2024 | 76.10M | 2.84% |
Mar 19, 2024 | 74.00M | -1.73% |
Mar 18, 2024 | 75.30M | 1.76% |
Mar 15, 2024 | 74.00M | -3.14% |
Mar 14, 2024 | 76.40M | -0.65% |
Mar 13, 2024 | 76.90M | 1.32% |
Mar 12, 2024 | 75.90M | -2.94% |
Mar 11, 2024 | 78.20M | -1.39% |
Mar 8, 2024 | 79.30M | 2.45% |
Mar 7, 2024 | 77.40M | -1.78% |
Mar 6, 2024 | 78.80M | 1.03% |
Mar 5, 2024 | 78.00M | -4.76% |
Mar 4, 2024 | 81.90M | 1.61% |
Mar 1, 2024 | 80.60M | 1.64% |
Feb 29, 2024 | 79.30M | -3.53% |
Feb 28, 2024 | 82.20M | 1.99% |
Feb 27, 2024 | 80.60M | 2.68% |
Feb 26, 2024 | 78.50M | -2.61% |
Feb 23, 2024 | 80.60M | 7.04% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eagle Pharmaceuticals | 65.37M |
HCW Biologics | 64.19M |
Enzo Biochem | 64.03M |
Turnstone Biologics | 63.51M |
Leap Therapeutics | 63.49M |
Matinas BioPharma Holdings | 62.05M |
Theratechnologies | 61.61M |
Gain Therapeutics | 61.56M |